Memory Enhancement Drugs Show Promise But Face Growing Scrutiny

In our aging society, with an increased urgency to develop new compounds that target serious illnesses like Alzheimer's and Parkinson's disease, memory enhancement drugs are becoming a big business. But these same drugs are also creating a growing ethical controversy over their potential off-label uses, such as taking these drugs as "performance enhancers" to gain a competitive advantage in the workplace. These issues, along with the biochemistry of memory, are explored in a recent article.